Neonc Technologies Holdings, Inc.(NTHI)

Biotechnology · Calabasas, CA

$3.01+0.09 (+3.08%)

Delayed quote: Oct 6, 2026, 1:34 PM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T17:37:30.651Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:37:30.651Z.

Quote observation: 2026-10-06T17:34:54.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 78,054,917
Total debt · period ending 2026-06-30: 328,217
Cash · period ending 2026-06-30: 1,973,420
TTM free cash flow · period ending 2026-06-30: -21,156,684

FMP input reference: 2d3a9198413857e44d8ff08287218970dc762668c083e85858692cc7a401d48f

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NTHI EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

NTHI Competitors' EV/FCF Ratio

NTHI

Neonc Technologies Holdings, Inc.

Current

Market Cap

$78.05M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INO

Inovio Pharmaceuticals, Inc.

vs NTHI

Market Cap

$78.07M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SERA

Sera Prognostics, Inc.

vs NTHI

Market Cap

$77.15M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LUNG

Pulmonx Corporation

vs NTHI

Market Cap

$77.08M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HYPR

Hyperfine, Inc.

vs NTHI

Market Cap

$76.64M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Outset Medical, Inc.

vs NTHI

Market Cap

$76.22M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTOR

Citius Oncology, Inc.

vs NTHI

Market Cap

$79.96M

EV/FCF Ratio

N/A

TTM Avg

816.68x

3Y Avg

816.68x

5Y Avg

816.68x

SKIN

SkinHealth Systems Inc.

vs NTHI

Market Cap

$76.14M

EV/FCF Ratio

14.25x

TTM Avg

14.85x

3Y Avg

42.42x

5Y Avg

42.42x

NTRB

Nutriband Inc.

vs NTHI

Market Cap

$80.11M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACRV

Acrivon Therapeutics, Inc. Common Stock

vs NTHI

Market Cap

$80.90M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Neonc Technologies Holdings, Inc. (NTHI)	$78.05M	N/A	N/A	N/A	N/A
Inovio Pharmaceuticals, Inc. (INO)vs ›	$78.07M	N/A	N/A	N/A	N/A
Sera Prognostics, Inc. (SERA)vs ›	$77.15M	N/A	N/A	N/A	N/A
Pulmonx Corporation (LUNG)vs ›	$77.08M	N/A	N/A	N/A	N/A
Hyperfine, Inc. (HYPR)vs ›	$76.64M	N/A	N/A	N/A	N/A
Outset Medical, Inc. (OM)vs ›	$76.22M	N/A	N/A	N/A	N/A
Citius Oncology, Inc. (CTOR)vs ›	$79.96M	N/A	816.68x	816.68x	816.68x
SkinHealth Systems Inc. (SKIN)vs ›	$76.14M	14.25x	14.85x	42.42x	42.42x
Nutriband Inc. (NTRB)vs ›	$80.11M	N/A	N/A	N/A	N/A
Acrivon Therapeutics, Inc. Common Stock (ACRV)vs ›	$80.90M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

NTHI EV/FCF Ratio Metrics

NTHI Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics